Effect of Captopril on Toll Like Receptor Expression in Adjuvant Induced Arthritis

Effect of Captopril on Toll Like Receptor Expression in Adjuvant Induced Arthritis

Rheumatoid arthritis (RA) is an inflammatory disease with autoimmune origin that affect joints firstly and then progress to be a systemic disease. Toll like receptor (TLR) play an important role in the evolution and progression of this disease. Captopril is an angiotensin enzyme inhibitor (ACEI)...

Full description

Bibliographic Details
Main Authors:	Assim Oday Farooq, Nadia Hameed Mohammed
Format:	Article
Language:	English
Published:	College of Pharmacy / Mustansiriyah University 2022-07-01
Series:	Al-Mustansiriyah Journal of Pharmaceutical Sciences
Subjects:	Rheumatoid arthritis, Captopril, Toll like receptor
Online Access:	https://ajps.uomustansiriyah.edu.iq/index.php/AJPS/article/view/825

Similar Items

Emerging role of endosomal Toll-like receptors in rheumatoid arthritis
by: Ryan eThwaites, et al.
Published: (2014-01-01)

Contribution of Toll-Like Receptors and the NLRP3 Inflammasome in Rheumatoid Arthritis Pathophysiology
by: Unterberger S, et al.
Published: (2021-07-01)

Toll-Like Receptors
by: Aycan Kundakcı, et al.
Published: (2012-08-01)

ROLE OF TOLL-LIKE RECEPTORS AND THEIR ENDOGENOUS LIGANDS IN THE PATHOGENESIS OF RHEUMATOID ARTHRITIS: A REVIEW OF LITERATURE
by: M. Yu. Volkov
Published: (2016-03-01)

Targeting Toll-like Receptor (TLR) Pathways in Inflammatory Arthritis: Two Better Than One?
by: Sandra Santos-Sierra
Published: (2021-08-01)

Toll-like receptor agonists as cancer vaccine adjuvants
by: Donghwan Jeon, et al.
Published: (2024-12-01)

Toll-like receptors in the pathogenesis of autoimmune diseases: recent and emerging translational developments
by: Duffy L, et al.
Published: (2016-08-01)

Candida and Toll-Like Receptors
by: Şayeste Demirezen, et al.
Published: (2012-12-01)

A Toll-like Receptor-Activating, Self-Adjuvant Glycan Nanocarrier
by: Daping Xie, et al.
Published: (2022-05-01)

HMGB1 and Toll-like receptors: potential therapeutic targets in autoimmune diseases
by: Wenxuan Ren, et al.
Published: (2023-09-01)

The Role of Toll-Like Receptors in Breast Cancer
by: Negin Nokhandani, et al.
Published: (2019-08-01)

Toll-Like Receptor Agonists as Adjuvants for Allergen Immunotherapy
by: Max E. Kirtland, et al.
Published: (2020-11-01)

A proteomic analysis of serum-derived exosomes in rheumatoid arthritis
by: Hirotaka Tsuno, et al.
Published: (2018-11-01)

Identification and characterization of toll-like receptor (TLR) 2 and 4 mutations in colorectal
by: Davoodi, Homa
Published: (2009)

RANK+TLR2+ myeloid subpopulation converts autoimmune to joint destruction in rheumatoid arthritis
by: Weixin Zhang, et al.
Published: (2023-05-01)

Toll-like receptors and atherosclerosis
by: Jerko Barbić, et al.
Published: (2009-02-01)

Nod-like receptors in inflammatory arthritis
by: Sahib Singh Madahar, et al.
Published: (2024-02-01)

Toll-Like Receptors Regulate the Development and Progression of Renal Diseases
by: Minghui Liu, et al.
Published: (2020-12-01)

Neuronal toll like receptor 9 contributes to complete Freund’s adjuvant-induced inflammatory pain in mice
by: Yu Chen, et al.
Published: (2022-10-01)

Counting the Toll of Inflammation on Schizophrenia—A Potential Role for Toll-like Receptors
by: Saahithh Redddi Patlola, et al.
Published: (2023-07-01)

TOLL-LIKE RECEPTORS IN CHRONIC LYMPHOCYTIC LEUKEMIA
by: Marta Muzio, et al.
Published: (2012-01-01)

The role of Toll-like receptors in skin diseases
by: Joanna Bacharewicz, et al.
Published: (2014-09-01)

Interplay of Chemokines Receptors, Toll-like Receptors, and Host Immunological Pathways
by: Yuan-Tung Chu, et al.
Published: (2023-08-01)

Prognostic role of Toll-like receptors in cancer: a meta-analysis
by: Wang Q, et al.
Published: (2018-07-01)

Polymorphisms of toll-like receptor 2 and 4 genes in Chagas disease
by: German Zafra, et al.
Published: (2008-02-01)

Roles of Toll-Like Receptors in Nitroxidative Stress in Mammals
by: Yao Li, et al.
Published: (2019-06-01)

Structural Modification of the Antidepressant Mianserin Suggests That Its Anti-inflammatory Activity May Be Independent of 5-Hydroxytryptamine Receptors
by: Sandra Sacre, et al.
Published: (2019-05-01)

Mannose Receptor Ligands Regulate the Gene Expression of Toll-like Receptors in Chicken Monocytes
by: Li Yan, et al.
Published: (2013-10-01)

Toll-like receptors in dermatology, venereology, and leprosy
by: Sneha Gandhi, et al.
Published: (2021-01-01)

Differential synovial tissue expression of TLRs in seropositive and seronegative rheumatoid arthritis: A preliminary report
by: Alzahraa Abdelwahab, et al.
Published: (2021-01-01)

Toll‐like receptors in pathogenesis of neurodegenerative diseases and their therapeutic potential
by: Yosef Tsegaye Dabi, et al.
Published: (2023-04-01)

PRELIMINARY STUDIES OF INTERACTION BETWEEN NANOTUBES AND TOLL-LIKE RECEPTORS
by: MAGDALENA A. MOZOLEWSKA, et al.
Published: (2014-10-01)

Is it possible to use the Toll-like receptors as biomarkers for neonatal sepsis? Review of the recent literature
by: Irina Melinda Baizat, et al.
Published: (2022-09-01)

Effects of Metal Oxide Nanoparticles on Toll-Like Receptor mRNAs in Human Monocytes
by: Vladislav A. Vasilichin, et al.
Published: (2020-01-01)

Decreased Toll-like Receptor (TLR) 2 and 4 Expression in Spermatozoa in Couples with Unexplained Recurrent Spontaneous Abortion (URSA)
by: Nasrin Sereshki, et al.
Published: (2019-11-01)

A Role of Intracellular Toll-Like Receptors (3, 7, and 9) in Response to <i>Mycobacterium tuberculosis</i> and Co-Infection with HIV
by: Huy Nguyen, et al.
Published: (2020-08-01)

Innate immunity drives pathogenesis of rheumatoid arthritis
by: Maria I. Edilova, et al.
Published: (2021-04-01)

Toll-Like Receptors: Are They Taking a Toll on the Heart in Viral Myocarditis?
by: Kasper Favere, et al.
Published: (2021-05-01)

Genotypic analysis of Asp299Gly and Thr399Ile polymorphisms of TLR4 in Egyptian patients with rheumatoid arthritis and systemic lupus
by: Hanan A. Taha, et al.
Published: (2014-01-01)

Serum soluble toll-like receptor 4 and risk for clinical severity in COVID-19 patients
by: Maha E. Houssen, et al.
Published: (2024-01-01)